Anika Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0352551081

SecurityANIK / Anika Therapeutics, Inc.
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership58,828 shares
Latest Disclosed Value $ 853,006
Engineers Gate Manager LP reports 46.06% increase in ownership of ANIK / Anika Therapeutics, Inc.

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 58,828 shares of Anika Therapeutics, Inc. (US:ANIK) valued at $853,006 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 40,276 shares of Anika Therapeutics, Inc.. This represents a change in shares of 46.06% during the quarter. The current value of the position is $847,711 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANIKA THERAPEUTICS COM 035255108 58,828 18,552 46.06 853 120.41 0.0107
2026-02-17 2025-12-31 13F ANIKA THERAPEUTICS COM 035255108 40,276 16,150 66.94 387 71.24 0.0046
2025-11-14 2025-09-30 13F ANIKA THERAPEUTICS COM 035255108 24,126 7,658 46.50 227 29.89 0.0026
2025-08-14 2025-06-30 13F ANIKA THERAPEUTICS COM 035255108 16,468 -6,011 -26.74 174 -48.37 0.0022
2025-05-15 2025-03-31 13F ANIKA THERAPEUTICS COM 035255108 22,479 -9,474 -29.65 338 -35.81 0.0057
2025-02-14 2024-12-31 13F ANIKA THERAPEUTICS COM 035255108 31,953 18,065 130.08 526 53.06 0.0092
2024-11-14 2024-09-30 13F ANIKA THERAPEUTICS COM 035255108 13,888 -7,887 -36.22 343 -37.75 0.0067
2024-08-14 2024-06-30 13F ANIKA THERAPEUTICS COM 035255108 21,775 -6,123 -21.95 552 -22.18 0.0124
2024-05-15 2024-03-31 13F ANIKA THERAPEUTICS COM 035255108 27,898 814 3.01 709 15.50 0.0187
2024-02-14 2023-12-31 13F ANIKA THERAPEUTICS COM 035255108 27,084 2,562 10.45 614 34.43 0.0175
2023-11-14 2023-09-30 13F ANIKA THERAPEUTICS COM 035255108 24,522 24,522 457 0.0169
2022-11-14 2022-09-30 13F ANIKA THERAPEUTICS COM 035255108 0 -25,816 -100.00 0 -100.00
2022-08-15 2022-06-30 13F ANIKA THERAPEUTICS COM 035255108 25,816 25,816 576 0.0211
2021-11-15 2021-09-30 13F ANIKA THERAPEUTICS COM 035255108 0 -12,531 -100.00 0 -100.00
2021-08-16 2021-06-30 13F ANIKA THERAPEUTICS COM 035255108 12,531 -6,139 -32.88 542 -28.87 0.0349
2021-05-17 2021-03-31 13F ANIKA THERAPEUTICS COM 035255108 18,670 3,660 24.38 762 12.22 0.0377
2021-02-16 2020-12-31 13F ANIKA THERAPEUTICS COM 035255108 15,010 -2,486 -14.21 679 9.69 0.0294
2020-11-16 2020-09-30 13F ANIKA THERAPEUTICS COM 035255108 17,496 -3,910 -18.27 619 -23.39 0.0290
2020-08-17 2020-06-30 13F ANIKA THERAPEUTICS COM 035255108 21,406 1,231 6.10 808 38.59 0.0411
2020-05-15 2020-03-31 13F ANIKA THERAPEUTICS COM 035255108 20,175 13,339 195.13 583 64.69 0.0420
2020-02-14 2019-12-31 13F ANIKA THERAPEUTICS COM 035255108 6,836 -5,646 -45.23 354 -48.32 0.0156
2019-11-14 2019-09-30 13F ANIKA THERAPEUTICS COM 035255108 12,482 -8,010 -39.09 685 -17.67 0.0348
2019-08-14 2019-06-30 13F ANIKA THERAPEUTICS COM 035255108 20,492 -8,931 -30.35 832 -6.52 0.0459
2019-05-15 2019-03-31 13F ANIKA THERAPEUTICS COM 035255108 29,423 29,423 890 0.0539
2018-11-01 2018-09-30 13F ANIKA THERAPEUTICS COM 035255108 0 -23,972 -100.00 0 -100.00
2018-08-03 2018-06-30 13F ANIKA THERAPEUTICS COM 035255108 23,972 23,972 767 0.0598
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.